Achievable logoAchievable logo
USMLE/1
Sign in
Sign up
Purchase
Textbook
Support
How it works
Resources
Exam catalog
Mountain with a flag at the peak
Textbook
Introduction
1. Anatomy
2. Microbiology
3. Physiology
4. Pathology
4.1 General pathology
4.2 Central and peripheral nervous system
4.3 Cardiovascular system
4.4 Respiratory system
4.5 Hematology and oncology
4.5.1 Coagulation cascade
4.5.2 Blood cell lineages
4.5.3 Anemia fundamentals
4.5.4 Thalassemia
4.5.5 Sideroblastic anemia
4.5.6 Macrocytic anemias
4.5.7 Hemolytic anemias
4.5.8 Sickle cell disease (SCD)
4.5.9 Hereditary spherocytosis (HS)
4.5.10 Disorders of coagulation
4.5.11 Hypercoagulable disorders (Thrombophilias)
4.5.12 Platelet disorders
4.5.13 Leukemias
4.5.14 Lymphomas
4.5.15 Polycythemia vera
4.5.16 Miscellaneous disorders
4.5.17 Additional information
4.6 Gastrointestinal pathology
4.7 Renal, endocrine and reproductive system
4.8 Musculoskeletal system
5. Pharmacology
6. Immunology
7. Biochemistry
8. Cell and molecular biology
9. Biostatistics and epidemiology
10. Genetics
11. Behavioral science
Wrapping up
Achievable logoAchievable logo
4.5.14 Lymphomas
Achievable USMLE/1
4. Pathology
4.5. Hematology and oncology

Lymphomas

7 min read
Font
Discuss
Share
Feedback

Lymphomas are malignancies that arise in lymph nodes and other lymphoid tissues. They’re broadly divided into Hodgkin’s lymphoma (HD) and non-Hodgkin’s lymphomas (NHL).

  • Hodgkin’s lymphoma (HD) is characterized by the presence of Reed-Sternberg cells.
  • Non-Hodgkin’s lymphomas (NHL) are more common than HD and do not show Reed-Sternberg cells.
  • B-cell NHL is more common than T-cell NHL.

Characteristics of common non-Hodgkin’s lymphomas

Type Features
Diffuse large B cell lymphoma Most common NHL. Commonly seen in the chest, neck, armpit, and abdomen. Associated with HIV and EBV. Shows diffuse sheets of large malignant lymphoid cells.
Follicular lymphoma Associated with t(14;18) and overexpression of anti-apoptotic bcl2. More common in adults. Appears as malignant follicles, typically with lack of a mantle zone, uniformly filled with malignant lymphoid cells and loss of normal lymph node architecture. Presents with generalized painless lymphadenopathy.
Cutaneous T cell lymphoma Involves the skin. Presents as rash, plaques, and dry, itchy, eczema-like lesions; may also cause lymphadenopathy and hepatosplenomegaly. Mycosis fungoides shows infiltration of skin by malignant T cells with cerebriform nuclei (Sezary cells) and intraepidermal collections of atypical cells called Pautrier’s microabscesses. Sezary syndrome occurs when malignant T cells (Sezary cells) invade the bloodstream.
Small cell lymphocytic lymphoma Counterpart of CLL in lymph nodes. Shows pseudo-follicles of mature-looking malignant lymphoid cells and smudge cells. B-cell origin. Autoantibodies to RBCs and platelets may be seen, along with hypogammaglobulinemia and monoclonal Ig spikes. May involve bone marrow.
Nodal marginal zone lymphoma Arises from B cells. Seen in older persons with HCV. Presents with lymphadenopathy and B symptoms.
Mucosa associated lymphoid tissue lymphoma or MALTomas or extranodal marginal zone lymphomas Arises in MALT tissues of the GIT, respiratory tracts, thyroid, etc. Associated with H.pylori.
Anaplastic large cell lymphoma More common in young adults and children. Ki 1 or CD30+. Presents with lymphadenopathy; bone marrow and CNS involvement may occur. Malignant cells are cytotoxic T cells. Shows anaplastic large cells with horseshoe nuclei and nuclear inclusions (doughnut cells).
Burkitt’s lymphoma Associated with EBV infections and t(8;14). Has endemic and sporadic forms. Shows a “starry sky” appearance with diffuse blue lymphocytes with scant cytoplasm interspersed with tingible-body macrophages*; Ki-67 positive. Can progress to leukemia. Jaw and GI tract lesions are more common.
CNS lymphoma May be primary or secondary; may also involve eyes, spinal cord, and meninges. Most are diffuse large B-cell lymphomas. Associated with AIDS and immunosuppression. Presents with headache, nausea, vomiting, seizures, double vision, hearing loss, and arm or leg weakness.
T-Lymphoblastic lymphoma/leukemia Rare; mostly seen in teens and young adults. Considered either lymphoma or ALL depending on bone marrow involvement. Origin is thymus. Presents as a mediastinal mass with dyspnea and swollen face and arms. Mature-looking T cells on histology.
Mantle cell lymphoma Develops from the mantle zone of lymph nodes. B-cell origin. Presents with lymphadenopathy and GIT involvement. Associated with overexpression of cyclin D1 and t(11;14). Seen in older males.
Adult T cell leukemia/lymphoma More common in Japan, the Caribbean, and Africa. Associated with HTLV-1. Seen in adults. May present acutely or chronically. Skin, liver, lung, and lymph node involvement may occur. Hypercalcemia and immunocompromise can occur. Histology shows “flower cells,” which are malignant lymphocytes with a convoluted nucleus.

*tingible-body macrophages are histiocytes phagocytosing apoptotic bodies.

Mantle cell lymphoma
Mantle cell lymphoma

Monocytoid B-cells (red arrow) and plasmacytoid cells (white arrowheads) are often found in marginal zone lymphoma

Follicular lymphoma
Follicular lymphoma

Follicular dendritic cells are a prominent feature of follicle center fragments present in samples of follicular lymphoma.

Burkitt lymphoma
Burkitt lymphoma

The CHOP regimen (cyclophosphamide, doxorubicin [hydroxydaunorubicin], vincristine, and prednisone) is used to treat NHL. Other treatments include rituximab, intrathecal methotrexate, CAR -T cell immunotherapy, stem cell transplantation, and radiotherapy. Hyper-CVAD, CODOX-M, and EPOCH are chemotherapy regimens used for Burkitt’s lymphoma.

Classification and features of Hodgkin’s lymphoma or disease

Classic Hodgkin’s disease
Nodular sclerosis Most common. Nodular pattern with fibrotic bands; lacunar type Reed-Sternberg cells are seen.
Mixed cellularity Diffuse pattern with a mixed infiltrate; classic Reed-Sternberg cells are seen. Common sites are the abdomen and spleen. Associated with HIV.
Lymphocyte predominant Better prognosis. Prominent lymphocytic infiltrate.
Lymphocyte depletion Bad prognosis. Associated with HIV and EBV. Diffuse pattern with many Reed-Sternberg cells and fewer lymphocytes.
Nodular lymphocyte predominant
Less common and slow growing compared to classic HD. Reed-Sternberg cells are absent or few. Lymphocytic and histiocytic (LH) or “popcorn cells” are seen on histology. CD20+, CD15+ and CD30+. Associated with HLA-DRB1 and HLA-DQB1.

Hodgkin’s disease presents with lymphadenopathy (commonly in the axilla, chest, groin, and abdomen), B symptoms, and hepatosplenomegaly. The age distribution of HD is bimodal, occurring more frequently in the 15-35 and >60 year age groups.

Chemotherapy regimens include:

  • MOPP regimen consisting of nitrogen mustard, oncovin (vincristine), procarbazine, and prednisone
  • ABVD regimen consisting of adriamycin (doxorubicin), bleomycin, vinblastine, and dacarbazine
  • Other regimens like MOP-BAP and ChIVPP

Stem cell transplantation and radiotherapy can also be used.

Reed-Sternberg cell in Hodgkin's lymphoma
Reed-Sternberg cell in Hodgkin's lymphoma

Nodular lymphocyte predominant HD is treated by local excision, radiotherapy, or close observation. Rituximab plus chemotherapy like CHOP can be used for advanced disease.

Staging of Hodgkin’s disease: Staging involves a combination of symptoms plus imaging techniques like CT scan. Ann Arbor classification is used for staging. Spleen and thymus are included as lymphatic areas.

Stage I: A single lymph node area or single extranodal site

Stage II: Two or more lymph node areas on the same side of the diaphragm

Stage III: Lymph node areas on both sides of the diaphragm

Stage IV: Disseminated disease or involvement of multiple extranodal organs, liver, or bone marrow involvement

A: Absence of B symptoms

B: Presence of B symptoms

Suffix S: Splenic involvement

Staging of Hodgkins lymphoma
Staging of Hodgkins lymphoma

Sign up for free to take 4 quiz questions on this topic

All rights reserved ©2016 - 2026 Achievable, Inc.